- Report
- November 2026
- 229 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 233 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 189 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 175 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 444 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 228 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 278 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 191 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 224 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 239 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 176 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 148 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 308 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 194 Pages
Global
From €4648EUR$4,950USD£3,877GBP
- Report
- November 2026
- 224 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 461 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 137 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 174 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 208 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 225 Pages
Global
From €5493EUR$5,850USD£4,582GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more